What is Newtopia Inc?
operates as a tech-enabled whole health platform primarily in the United States.
NEWUF · Verdict
Limited reward · high risk
NEWUF stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
NEWUF · Verdict
Above average
Above average
Current ratio 0.22
Rev -5.0% CAGR · earnings -5.1%
-23% free-cash-flow margin
-67% net margin · -650% ROE
Model-based scoring. For information only — not financial advice.
operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 86.63K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.